Lyra Therapeutics, Inc.
LYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$93 | -$63 | -$55 | -$44 |
| Dep. & Amort. | $0 | $0 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $7 | $6 | $5 | $3 |
| Change in WC | -$6 | -$5 | $5 | $14 |
| Other Non-Cash | $23 | -$2 | $1 | $2 |
| Operating Cash Flow | -$70 | -$63 | -$43 | -$26 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$0 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$48 | -$122 | -$65 | $0 |
| Inv. Sales/Matur. | $131 | $111 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $80 | -$13 | -$65 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9 | $69 | $100 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$4 | -$4 | -$0 |
| Financing Cash Flow | $9 | $66 | $96 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $19 | -$10 | -$12 | -$29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24 | $34 | $46 | $75 |
| End Cash | $43 | $24 | $34 | $46 |
| Free Cash Flow | -$72 | -$64 | -$44 | -$29 |